Plain-English translation of NCT07575399 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called for people with obesity or overweight who are already having good results with a similar injectable weight loss medication. Researchers want to see if switching to this new treatment works just as well or better, and if it's safe and well tolerated. The study will compare two different dosing schedules to find the best approach.
Many people are successfully losing weight on current injectable medications, but researchers believe this new treatment could offer an even better option. This trial will help doctors understand whether patients who are doing well on their current medication can benefit from switching to this alternative.
You likely qualify if…
You likely don't qualify if…
If you join, you will be randomly assigned to receive one of two dosing schedules of the new medication while stopping your current injectable. You'll come in for visits where the study team will monitor how well the treatment works, check your weight and health, and watch for any side effects. The study will track how you respond to the medication and compare it to how you were doing on your previous treatment.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States